BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ZContent.net//ZapCalLib 1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
SUMMARY:Advancing Electrochemical Platforms for Breast Cancer Diagnostics
LOCATION:Chemistry A101
TZID:America/Denver
DTSTART:20251008T160000
UID:2026-05-19-01-08-50@natsci.colostate.edu
DTSTAMP:20260519T010850
Description:About the seminar:\n\nBreast cancer is a leading cause of death
  among women globally and is thereby a\nmajor threat to women’s health. 
 Five-year survival rates decrease drastically with late-stage\ndiagnosis\,
  so early detection and treatment of breast cancer is vital for reducing m
 ortality rates.\nConventional methods for breast cancer diagnosis based on
  imaging are costly and non-definitive\, while gold standard biomarker-bas
 ed methods are time consuming\, expensive\, and\nrequire trained personnel
  to be carried out. Therefore\, a low-cost\, easy-to-use\, fast\, and reli
 able\ntest that can detect breast cancer early on to increase chances of s
 urvival must be developed.\nRecently\, electrochemical sensing platforms h
 ave become increasingly popular for point-of-care\napplications due to the
 ir superior detection capabilities and ease of use compared to traditional
 \nmethods. However\, electrochemical platforms for HER2 positive breast ca
 ncer diagnosis require\nfurther development before implementation into cli
 nical settings is feasible. Magneto-electrochemical sensing (MES) platform
 s\, which combine magnetic bead manipulation for\nimmunoassay steps with e
 lectrochemical sensing\, are viable options for the point-of-care\ndetecti
 on of HER2 positive breast cancer protein biomarkers\, thereby facilitatin
 g disease\ndiagnosis. MES platforms have the potential to be applied to ot
 her cancer biomarkers\, which will\nenable timely diagnosis and prognosis 
 across multiple cancer types. 4:00 pm
END:VEVENT
END:VCALENDAR